Business Context and Reporting Period
Company: Medifast, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2005
Business Overview: Medifast is engaged in the production, distribution, and sale of weight management, disease management, and meal replacement products. Key brands include Medifast(R), Hi-Energy(R), and Take Shape for Life(TM). Products are sold through direct-to-consumer channels, independent health advisors, medical professionals, and weight loss clinics.
Key Financial Metrics
| Metric | 2005 | 2004 |
|---|---|---|
| Revenue | $40,129,000 | $27,340,000 |
| Gross Profit | $29,968,000 | $20,594,000 |
| Gross Margin | 74.7% | 75.3% |
| Operating Income | $4,074,000 | $3,004,000 |
| Net Income | $2,727,000 | $1,747,000 |
| Net Income Attributable to Common Shareholders | $2,436,000 | $1,729,000 |
| Diluted EPS | $0.19 | $0.14 |
| Cash Flow from Operations | $3,213,000 | $1,902,000 |
| Total Assets | $30,545,000 | $25,968,000 |
| Total Liabilities | $8,524,000 | $6,762,000 |
| Long-Term Debt (net of current) | $3,977,000 | $4,256,000 |
| Line of Credit Outstanding | $633,000 | $369,000 |
| Cash and Cash Equivalents | $1,484,000 | $612,000 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 47% to $40.1 million, driven by expanded direct marketing campaigns (print, web, TV) and growth in the Take Shape for Life division.
- Profitability: Operating income rose 36% to $4.1 million. Net income attributable to common shareholders increased 41% to $2.4 million.
- Expense Increases: Selling, General, and Administrative (SG&A) expenses increased by $8.3 million (47%) due to higher advertising spend and business scale. Cost of sales increased $3.4 million, primarily due to higher fuel charges.
- Capital Structure: All Series B and Series C Convertible Preferred Stock were converted to common stock during 2005, eliminating preferred dividend requirements ($291,000 in 2005 vs. $18,000 in 2004).
- Investing Activities: Net cash used in investing activities was $2.0 million, primarily for the purchase of intangible assets and property/equipment.
Outlook, Risks, and Unusual Items
- Subsequent Event: On January 17, 2006, the Company sold the Consumer Choice Systems division assets for $1.82 million, recorded as a 10-year note receivable collateralized by 50,000 shares of Medifast stock.
- IT Infrastructure: In November 2005, the Company began implementing an Enterprise Resource Planning (ERP) solution to upgrade technology and improve manufacturing processes.
- Seasonality: The Company noted a decrease in traditional seasonality (typically weak in Nov/Dec) due to increased consumer awareness of health benefits.
- Risks: The Company faces inherent product liability risks associated with ingested products. Operations are subject to regulation by the FDA, FTC, and other agencies regarding labeling and claims.
- Accounting Changes: The Company is evaluating the impact of FAS 123R (Share-Based Payment), effective January 1, 2006, which will require expensing the fair value of stock options.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the 47% revenue growth and the specific contribution of the Take Shape for Life network versus direct-to-consumer sales.
- Debt Covenants: Review the terms of the $5 million revolving line of credit and the various term loans to ensure compliance with covenants, given the increase in debt utilization.
- Intangible Assets: Assess the valuation and amortization schedule of the $6.5 million in net trademarks and intangibles, which represent a significant portion of total assets.
- Stock-Based Compensation: Monitor the impact of the upcoming adoption of FAS 123R on future net income, as the pro-forma impact in 2005 was a reduction of $280,000.
- Subsequent Sale: Confirm the collection status and terms of the $1.82 million note receivable from the January 2006 sale of the Consumer Choice Systems division.